Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.W.H | KHRNF | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > Khiron clinic network expending faster than anticipated.
View:
Post by FundyPicks on Mar 26, 2021 2:16am

Khiron clinic network expending faster than anticipated.

Latest Update: March 25th, 2021

On March 18, 2021, Khiron clinics network named Zerenia announced on Facebook the opening of their new clinic in Pereira, Colombia. This is ahead of our expectations. Following the recent opening on their new clinics in Cali and Bucaramanga, Colombia, the company announced its intention to open 3 new clinics by the end of Q2 (accelerating the pace of expansion). We were expecting those 3 clinics in 2 or 3 months but the first one arrived already in Q1. Increasing our confidence that the company is capitalizing quickly on its first mover advantage in Colombia B2C (Business to Consumer - Patients). We will follow closely their execution, but for now we are impressed.

To learn more, access for free to our research: https://www.stpierreresearch.com/khiron

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities